Post by
goldtech on Nov 15, 2024 1:08pm
Financings
If the 6 months interm results do not bring good results then the share price will surely be below 2 dollars and they will not be able to get funds from the tranche A warrants. Interesting to note Promis has never had warrants exercised in its history , so the odds are not in their favour. I am cautiously optimistic that we will succeed, but with a poor BOD and management crew.
Comment by
bball67 on Nov 18, 2024 10:04am
Goldtech, you say no warrants exercised in history. I exercised warrants. The biomarker results will be very positive, nothing to fear. The Tranche A Warrants will not be exercised because PMN will be bought out. I participated in the last two financings and heard Warma opine on this topic.
Comment by
goldtech on Nov 18, 2024 1:46pm
I think you are correct, or at least I hope you are. Being bought out or a JV on PMN310 is a win for us. What I take as being positive is that Sclarz, Gordon and Shaftmaster control over 40% of the Company and I dont believe they would sell this cheap.
Comment by
BottomBroker on Nov 19, 2024 2:08pm
Bball, what do you expect a buyout will look like? Your best guess.